Cygnus Inc (original) (raw)

About DBpedia

Cygnus, Inc. was a biotechnology company that dissolved in 2007. At its inception in 1985, Cygnus was engaged in development and manufacturing of transdermal drug delivery systems, including products for contraception, hormone therapy and smoking cessation. The company also developed the GlucoWatch, a non-invasive glucose monitoring devices for manufacture and commercialization. When GlucoWatch was launched in early 2002, the product sales of GlucoWatch were much lower than expected. According to the Company, the reasons for failure included adoption barriers for new technology, need for a paradigm shift in the management of diabetes, lack of widespread medical reimbursement, and performance characteristics of the device.

Property Value
dbo:abstract Cygnus, Inc. was a biotechnology company that dissolved in 2007. At its inception in 1985, Cygnus was engaged in development and manufacturing of transdermal drug delivery systems, including products for contraception, hormone therapy and smoking cessation. The company also developed the GlucoWatch, a non-invasive glucose monitoring devices for manufacture and commercialization. When GlucoWatch was launched in early 2002, the product sales of GlucoWatch were much lower than expected. According to the Company, the reasons for failure included adoption barriers for new technology, need for a paradigm shift in the management of diabetes, lack of widespread medical reimbursement, and performance characteristics of the device. (en)
dbo:wikiPageID 19756110 (xsd:integer)
dbo:wikiPageLength 4709 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1109802719 (xsd:integer)
dbo:wikiPageWikiLink dbr:San_Francisco dbc:Technology_companies_established_in_1985 dbr:Arbitration dbr:Infrastructure dbr:Smoking_cessation dbr:Glucose dbr:Animas_Corporation dbr:Hormone_therapy dbr:Paradigm_shift dbc:1985_establishments_in_California dbr:USD dbr:Dissolution_(law) dbr:Logical_possibility dbr:Daiichi_Sankyo dbr:Over-the-counter_(finance) dbc:Companies_based_in_Redwood_City,_California dbr:Biotechnology dbr:Nasdaq dbr:Ortho-McNeil_Pharmaceutical dbr:Market_capitalization dbr:Reimbursement dbr:Liquidate dbr:Transdermal dbr:Contraception dbr:Beneficiaries dbr:Healthcare_professionals dbr:10Q
dbp:wikiPageUsesTemplate dbt:Authority_control dbt:Reflist
dcterms:subject dbc:Technology_companies_established_in_1985 dbc:1985_establishments_in_California dbc:Companies_based_in_Redwood_City,_California
schema:sameAs http://viaf.org/viaf/8622150470104404330004
rdf:type owl:Thing yago:WikicatCompaniesBasedInRedwoodCity,California yago:WikicatCompaniesEstablishedIn1985 yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity yago:SocialGroup107950920
rdfs:comment Cygnus, Inc. was a biotechnology company that dissolved in 2007. At its inception in 1985, Cygnus was engaged in development and manufacturing of transdermal drug delivery systems, including products for contraception, hormone therapy and smoking cessation. The company also developed the GlucoWatch, a non-invasive glucose monitoring devices for manufacture and commercialization. When GlucoWatch was launched in early 2002, the product sales of GlucoWatch were much lower than expected. According to the Company, the reasons for failure included adoption barriers for new technology, need for a paradigm shift in the management of diabetes, lack of widespread medical reimbursement, and performance characteristics of the device. (en)
rdfs:label Cygnus Inc (en)
owl:sameAs freebase:Cygnus Inc http://viaf.org/viaf/8622150470104404330004 yago-res:Cygnus Inc wikidata:Cygnus Inc https://global.dbpedia.org/id/4iTvq
prov:wasDerivedFrom wikipedia-en:Cygnus_Inc?oldid=1109802719&ns=0
foaf:isPrimaryTopicOf wikipedia-en:Cygnus_Inc
is dbo:wikiPageWikiLink of dbr:Glucose_meter dbr:Seaport_Centre
is foaf:primaryTopic of wikipedia-en:Cygnus_Inc